Indexed keywords
D DIMER;
MESSENGER RNA;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
TISSUE PLASMINOGEN ACTIVATOR;
ADIPOSE DERIVED MESENCHYMAL STROMAL CELL;
ADIPOSE DERIVED STEM CELL;
ARTICLE;
CLEARANCE;
CONTROLLED STUDY;
DIABETIC PATIENT;
FIBRINOLYSIS;
HUMAN;
HUMAN TISSUE;
MESENCHYMAL STROMA CELL;
MICROTHROMBUS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT SAFETY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
ADIPOSE TISSUE;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
DIABETES MELLITUS, TYPE 2;
FEMALE;
FIBRINOLYSIS;
HUMANS;
MALE;
MESENCHYMAL STROMAL CELLS;
MIDDLE AGED;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
TISSUE PLASMINOGEN ACTIVATOR;
1
84856025288
Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia
Ruiz-Salmeron R, de la Cuesta-Diaz A, Constantino-Bermejo M, et al. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transplant 2011;20:1629-1639
(2011)
Cell Transplant , vol.20
, pp. 1629-1639
Ruiz-Salmeron, R.1
De La Cuesta-Diaz, A.2
Constantino-Bermejo, M.3
2
34547533472
Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts
Hashi CK, Zhu Y, Yang GY, et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A 2007;104:11915-11920
(2007)
Proc Natl Acad Sci U S A , vol.104
, pp. 11915-11920
Hashi, C.K.1
Zhu, Y.2
Yang, G.Y.3
3
33644805745
Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells
Nakagami H, Maeda K, Morishita R, et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005;25: 2542-2547
(2005)
Arterioscler Thromb Vasc Biol , vol.25
, pp. 2542-2547
Nakagami, H.1
Maeda, K.2
Morishita, R.3
4
84856973179
Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation
Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 2012;20:14-20
(2012)
Mol Ther , vol.20
, pp. 14-20
Prockop, D.J.1
Oh, J.Y.2
5
10744222119
Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives
Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004;109:656-663
(2004)
Circulation , vol.109
, pp. 656-663
Planat-Benard, V.1
Silvestre, J.S.2
Cousin, B.3
6
73349117463
Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots
Neuss S, Schneider RK, Tietze L, Knüchel R, Jahnen-Dechent W. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots. Cells Tissues Organs 2010;191:36-46
(2010)
Cells Tissues Organs , vol.191
, pp. 36-46
Neuss, S.1
Schneider, R.K.2
Tietze, L.3
Knüchel, R.4
Jahnen-Dechent, W.5
7
33947321575
UPAR-uPA-PAI-1 interactions and signaling: A vascular biologist's view
Binder BR, Mihaly J, Prager GW. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 2007;97:336-342
(2007)
Thromb Haemost , vol.97
, pp. 336-342
Binder, B.R.1
Mihaly, J.2
Prager, G.W.3
8
44349085988
Fibrinolysis: The key to new pathogenetic mechanisms
Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A. Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 2008; 15:923-929
(2008)
Curr Med Chem , vol.15
, pp. 923-929
Zorio, E.1
Gilabert-Estellés, J.2
España, F.3
Ramón, L.A.4
Cosín, R.5
Estellés, A.6
